ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Kairos Pharma Ltd

Kairos Pharma Ltd (KAPA)

1.37
-0.08
(-5.52%)
Closed February 17 4:00PM
1.374
0.004
(0.29%)
After Hours: 7:14PM

Kairos Pharma Ltd Financial Summary

The current KAPA market cap is 17.65M. The company's latest EPS is USD -0.1410 and P/E is -10.07.

Quarter End
USD ($)USD ($)USD ($)
Total Revenue
Operating Income
Net Income
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -1.94M-571k-1.71M
Net Income -2.15M-1.05M-1.81M
Quarter End
USD ($)USD ($)USD ($)
Total Assets
Total Liabilities
Total Equity
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 775k1.04M965k
Total Liabilities 1.94M2.22M3.04M
Total Equity -1.17M-1.18M-2.08M
Quarter End
USD ($)USD ($)USD ($)
Operating
Investing
Financing
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -412k-353k81k
Investing -109k N/A N/A
Financing 580k717k-425k
Market Cap 17.65M
Price to Earnings Ratio -10.07
Price to Sales Ratio 0
Price to Cash Ratio 197.22
Price to Book Ratio -8.78
Dividend Yield -

Share Statistics

Shares Outstanding 12.85M
Average Volume (1 week) 166.06k
Average Volume (1 Month) 1.07M
52 Week Change -65.65%
52 Week High 4.00
52 Week Low 0.851
Spread (Intraday) 0.08 (5.52%)

Company Info

Company Name Kairos Pharma Ltd
Address 108 w. 13th street suite 100
wilmington, delaware 19801
Website https://kairospharma.com
Industry pharmaceutical preparations (2834)